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ABSTRACT Molecular mechanisms of Kaposi’s sarcoma-associated herpesvirus (KSHV)
reactivation have been studied primarily by measuring the total or average activity
of an infected cell population, which often consists of a mixture of both nonre-
sponding and reactivating cells that in turn contain KSHVs at various stages of repli-
cation. Studies on KSHV gene regulation at the individual cell level would allow us
to better understand the basis for this heterogeneity, and new preventive measures
could be developed based on findings from nonresponding cells exposed to reacti-
vation stimuli. Here, we generated a recombinant reporter virus, which we named
“Rainbow-KSHV,” that encodes three fluorescence-tagged KSHV proteins (mBFP2-
ORF6, mCardinal-ORF52, and mCherry-LANA). Rainbow-KSHV replicated similarly to a
prototype reporter-KSHV, KSHVr.219, and wild-type BAC16 virus. Live imaging re-
vealed unsynchronized initiation of reactivation and KSHV replication with diverse ki-
netics between individual cells. Cell fractionation revealed temporal gene regulation,
in which early lytic gene expression was terminated in late protein-expressing cells.
Finally, isolation of fluorescence-positive cells from nonresponders increased dy-
namic ranges of downstream experiments 10-fold. Thus, this study demonstrates a
tool to examine heterogenic responses of KSHV reactivation for a deeper under-
standing of KSHV replication.
IMPORTANCE Sensitivity and resolution of molecular analysis are often compro-
mised by the use of techniques that measure the ensemble average of large cell
populations. Having a research tool to nondestructively identify the KSHV replication
stage in an infected cell would not only allow us to effectively isolate cells of inter-
est from cell populations but also enable more precise sample selection for ad-
vanced single-cell analysis. We prepared a recombinant KSHV that can report on its
replication stage in host cells by differential fluorescence emission. Consistent with
previous host gene expression studies, our experiments reveal the highly hetero-
genic nature of KSHV replication/gene expression at individual cell levels. The utiliza-
tion of a newly developed reporter-KSHV and initial characterization of KSHV replica-
tion in single cells are presented.
KEYWORDS KSHV, transcription, single cells, Kaposi’s sarcoma-associated
herpesvirus, LANA, ORF6, reactivation, gene expression, herpesviruses,
heterologous gene expression
Molecular and genetic heterogeneity, even among cells of a single tissue type orclonal line, is increasingly evident with the use of new single-cell technologies
(1–3). Next-generation sequencing (NGS) enables researchers to routinely obtain mil-
lions of sequence reads that reveal genomic mutations, transcriptome variations, and
epigenetic differences at the single-cell level (3–5). New developments in mass cytom-
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etry have also enabled analysis of cell surface protein expression and metabolites at
single-cell resolution (6–9). Thus, advancing single-cell technologies are revolutionizing
experimental approaches and allowing researchers to investigate cell-to-cell heteroge-
neity with unprecedented depth and understand biological outcomes as a sum of
individual effects.
Heterogenic cellular responses are especially profound when we consider herpes-
virus reactivation from latently infected cells as one of the biological events. Kaposi’s
sarcoma-associated herpesvirus (KSHV), also designated human herpesvirus 8, is one of
eight human herpesviruses and was discovered in 1994 (10). Since then, KSHV has been
identified as the causative agent of Kaposi’s sarcoma (10–12) and two human lym-
phoproliferative diseases, primary effusion lymphoma (PEL) and AIDS-related multicen-
tric Castleman’s disease (13–16). In those cancer cells, KSHV establishes latent infection
in which all but a few viral genes are silenced. External stimuli, such as inhibition of
histone deacetylase, expression of strong viral transactivator (ORF50/K-Rta), and/or
incubation with 12-O-tetradecanoylphorbol 13-acetate (TPA), trigger KSHV reactivation
from latently infected cells (17, 18). As with immune cell response to antigens, cell-to-
cell variation of KSHV reactivation has been documented (19, 20), along with hetero-
geneity of response among viral episomes in an individual host cell nucleus (21).
Therefore, a higher resolution of analyses is important to identify underlining molecular
mechanisms of such heterogenous responses. Since all viral genomes in an infected cell
are essentially identical, differences in response to stimulation likely are mediated by
host factors; this also makes studies on KSHV gene expression from the “designable”
viral minichromosome a unique tool to probe differences in the cellular environment
(21, 22).
Like other herpesviruses, KSHV gene transcription occurs in a cascade fashion and is
initiated by the expression of a strong transactivator, K-Rta (KSHV replication and
transactivation) (23, 24). K-Rta either directly or indirectly binds to viral promoters. By
doing so, K-Rta can activate at least 33 viral promoters in an isolated reporter study (25).
Those target genes include DNA replication-related genes (e.g., ORF6, ORF59, and K8)
and all of the KSHV long noncoding RNAs (PAN RNA, T1.5, and T0.7). Among the genes
activated in the early lytic replication phase, ORF6 is known as an early gene and
participates in viral DNA replication (26). KSHV ORF6 protein is a homolog of the herpes
simplex virus 1 (HSV-1) ICP8 and Epstein-Barr virus (EBV) BALF2 proteins. Similar to
those homologous proteins, KSHV ORF6 protein can bind to single-stranded DNA and
is essential for lytic DNA replication by forming a replication compartment (RC) (27).
After the onset of early gene expression, late genes that usually encode viral structural
proteins are expressed. Five viral proteins, ORF18, -30, -31, -34, and -66, were reported
to form a viral preinitiation complex (vPIC) for late gene transcription in the presence
of the newly replicating DNA (28–30). The expression of many KSHV structural proteins,
including ORF52 protein, then was transcribed by cellular RNA polymerase II.
On the other hand, a few proteins, including the latency-associated nuclear antigen
(LANA), are abundantly expressed in the nucleus during latent infection (31). LANA is
a multifunctional protein involved in the recruitment of cellular machineries for viral
DNA replication and segregation of the replicated viral DNAs to daughter cells through
interaction with cellular DNA replication factors, chromatin-modifying enzymes, and
mitotic apparatus (32–34). LANA directly binds to the terminal repeat (TR) region of the
viral genome and associates with nucleosomal proteins to tether to the host cell
chromatin (35, 36). Tight binding to the 35 copies of the TR sequences concentrates
LANA proteins on the KSHV genome in the nucleus of infected cells, which makes them
visible as “LANA dots” under fluorescence microscopy (37). Accordingly, a LANA dot
represents a single viral episome in the nucleus; therefore, the fluorescence signal can
be used to measure the viral DNA copy number in an infected cell nucleus (38).
In this study, we constructed a new reporter-KSHV that employs three different
fluorescent viral proteins to indicate the stage of KSHV lytic replication in individual
host cells. Using this construct, we found that KSHV replication and transcription are
indeed highly heterogeneous processes. By sorting reactivating cells from nonre-
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sponder cells in a culture dish, we improved the precision of transcription analyses to
reveal up- and downregulation of early gene expression in a replication stage-
dependent fashion from the same culture dish at any given time point.
RESULTS
Preparation of Rainbow-KSHV with BAC16. Isolation of different stages of KSHV
replicating cells from a dish can increase the resolution for a number of downstream
analyses. To perform such studies in a convenient manner, we designed a reporter-
KSHV that enables both visualization and isolation for cells of interest from the cell
population by flow cytometer. We selected three viral genes with different expression
kinetics for the following reasons: (i) ORF6 was selected because of its well-documented
function in the establishment of replication compartments (RCs) in infected cells that
should lead us to identify KSHV DNA replicating cells (39, 40); (ii) LANA was selected to
visualize location and track copy number of latent KSHV episomes during cell prolif-
eration (41); and (iii) ORF52 (tegument protein) was selected because of its higher
expression during replication. Fusion of enhanced green fluorescent protein (EGFP) to
the ORF52 N terminus also was shown to have little effect on the production of KSHV
virions in culture media (42). Three fluorescence tags (mBFP2, mCherry, and mCardinal)
were selected based on their relative brightness and separation of fluorescence emis-
sion peaks. GFP is also expressed from the EF1 promoter from the bacterial artificial
chromosome 16 (BAC16) backbone (22). Since the cDNA sequences of mBFP2 (blue)
and mCardinal (far-red) have 95% identity, we optimized codon usage of mCardinal to
alter the DNA sequence without changing the amino acid sequence to prevent
recombination between the two fluorescence tags (Table 1). Each fluorescence tag was
inserted sequentially with a two-step red recombination approach and expressed as a
fusion protein (Fig. 1). We reasoned that the expression of the fluorescence marker as
a fusion protein from the respective endogenous promoter would report KSHV gene
expression more closely to that of the natural KSHV replication cycles. Four individual
colors and combinations of merged fluorescence produced more than 7 colors; there-
fore, we called the reporter-KSHV “Rainbow-KSHV.” We also prepared two types of
mBFP2-ORF6 fusions (N-terminal fusion or C-terminal fusion) separately and compared
efficacies of KSHV gene expression.
Rainbow-KSHV gene expression. To establish Rainbow-KSHV-transfected iSLK
cells, BAC16-Rainbow was directly transfected into iSLK cells and selected with a high
concentration of hygromycin (1 mg/ml). Stably transfected cells were isolated and
pooled to avoid clone variations. First, the expression of the entire viral gene was
confirmed by KSHV PCR arrays after harvesting total RNAs at a different time point. All
of the KSHV open reading frames (ORFs) and viral long noncoding RNAs (PAN RNA, T1.5,
and T0.7) were induced in the presence of TPA and doxycycline. Although both the
N-terminally and C-terminally tagged mBFP-ORF6 virus expressed every KSHV gene,
N-terminal ORF6 showed lower overall threshold cycle (CT) values in the cells (Fig. 2A).
Accordingly, we decided to use Rainbow-KSHV with N-terminal ORF6 iSLK cells for
further analyses. Sodium butyrate and doxycycline also strongly induced reactivation,
including expression of all KSHV ORF proteins (see Fig. S1 in the supplemental material).
KSHV protein expression also was confirmed by immunoblotting (Fig. 2B). N-ORF6 was
found to have higher LANA expression than the C-ORF6 construct, which suggests the
presence of higher episome copy numbers.
Rainbow-KSHV replication. We next examined viral particle production in culture
supernatant. The results showed a clear increase of KSHV virions in culture media after
stimulation. Rainbow-KSHV produces amounts of virions in supernatant comparable to
those of rKSHV2.19 and about one-fourth of that produced by BAC16 wild-type virus
(Fig. 2C). De novo infection of the iSLK cells released mCardinal-ORF52, a tegument
protein, and therefore increased the number of mCardinal-positive cells. Numbers of
GFP-positive cells were also increased in a dose-dependent manner, and the infection
ratio was comparable with that of the BAC16 wild-type virus (Fig. 2D and E). Under
electron microscopy, we observed densely stained virus-like particles in both reacti-
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vated cells and purified supernatant (Fig. 2F). Together, these results confirmed that
fluorescence protein tags did not significantly interfere with viral DNA replication or
virion production.
Dynamic expression of fluorescence-tagged protein. We next reactivated the
cells for different time points, and we fixed and observed fluorescence signals in situ.
The mCherry-LANA fusion had unique nuclear localization patterns, known as LANA
dots, before reactivation (Fig. 3A). The red fluorescent protein (RFP)-LANA-encoding
recombinant KSHV was recently reported by Lieberman’s group; our Rainbow-KSHV
showed similar LANA expression patterns (41). The majority of the LANA dots were
TABLE 1 Primers, plasmids, and gene block DNA sequences used for BAC16 recombination (5=¡3=)
Primer, plasmid, or gene block Sequencea
mTagBFP2 cassette template, Addgene 142374
mTagBFP2 KpnI-S AAAGGTACCATGGTGTCTAAGGGCGAAGAGCTGATTA
mTagBFP2 SacII-AS AAACCGCGGTTAATTAAGCTTGTGCCCCAGTTTGCTAG
Template pEPkan-S, Addgene (plasmid 41017)
mTagBFP2-Kan AccI-S AAAGGTACCATTGTCTACTATGTGGACTACAGACTGGAAAGAATCAAGGAGGCCAACAACGAG
ACCTAGGGATAACAGGGTAATCGATTT
Kan AccI-AS AAAGGTACCGTAGACGCCAGTGTTACAACCAATTAACC
mBFP2-ORF6N-FW AGGGGACTCTGCGCGCTTAAGCGCCAAGCCATTATACACACGGGTTTTTTGTTGTCTTGGCCAATCGT
GTCTCCATGGTGTCTAAGGGCGAAGAGCTGATTA
mBFP2-ORF6N-RV TAGAGGTACCCGCAGGGACCAGTGGGGGCCGCAGACCCAATATTTTCCTCGAGGGTTTGTGGTCCCT
TTAGCGCATTAAGCTTGTGCCCCAGTTTGCTAG
mBFP2-ORF6C-FW GCTTTTTCCGTCCCCGGGCGTCCCAAGCCTGACAGTGGGTAAAAAACGAAAAATCGCATCCCTGCTCT
CTGACCTGGATTTGGTGTCTAAGGGCGAAGAGCTGATTAAGG
mBFP2-ORF6C-RV GGTCCATGGCTAGGGCTGACACATCGGCATAGACCGCCGCCAGTTCCTTTGCCATCGTTACGGGTAC
ACAACTAATTAAGCTTGTGCCCCAGTTTGCTA
mCardinal codon-optimized fragment (KpnI/SacII)
cloned into pBS SK vector with Gibson
assembly
CGACTCACTATAGGGCGAATTGGGTACCATGGTCAGCAAAGGCGAAGAGTTGATTAAGGAGA
ACATGCATATGAAACTGTATATGGAGGGGACTGTTAATAACCATCACTTCAAATGCACTAC
AGAAGGCGAAGGAAAGCCATATGAGGGCACTCAGACGCAACGGATTAAAGTTGTTGAGGGTG
GACCTTTGCCCTTTGCCTTCGACATACTGGCAACATGCTTTATGTATGGCTCCAAGACATTTATTA
ACCATACACAAGGAATACCCGACTTTTTCAAACAAAGTTTCCCAGAAGGATTCACATGGGAGAG
AGTGACGACTTATGAGGACGGGGGAGTCCTTACGGTAACCCAAGATACCTCATTGCAGGACGGG
TGCCTCATTTACAACGTGAAACTTAGGGGCGTCAACTTCCCATCTAACGGGCCAGTGATGCAGA
AAAAAACTCTTGGATGGGAAGCTACAACTGAGACGCTCTATCCTGCGGATGGCGGCCTGGAGGG
CCGCTGTGATATGGCCCTTAAGCTGGTAGGCGGTGGACATCTCCATTGCAATCTCAAAACTAC
GTACAGAAGCAAAAAACCCGCCAAAAATCTGAAGATGCCAGGCGTCTACTTTGTCGATAGAAG
GCTTGAGAGAATCAAGGAGGCGGATAACGAAACTTATGTCGAGCAACATGAAGTGGCGGTAGC
CAGGTACTGCGACCTTCCCTCAAAGCTGGGTCATAAGTTGAATGGGATGGATGAACTGTACAA
GTAACCGCGGTGGAGCTCCAGCTTTTGTTCC
Template pEPkan-S, Addgene (plasmid 41017)
mCardinal Kan AccI-S AAAGGTACCGTCTACTTTGTCGATAGAAGGCTTGAGAGAATCAAGGAGGCGGATAACGAAAC
TTATAGGGATAACAGGGTAATCGATTT
Kan AccI-AS AAAGGTACCGTAGACGCCAGTGTTACAACCAATTAACC
mCardinal-ORF52N-FW AGCTGGGTATAAAGGAGGGATTTGGGCTTTTGTTGTGAGCATCACCAACACGTACATCTACGCGTA
CCTGACATGGTCAGCAAAGGCGAAGAGT
mCardinal-ORF52N-RV TCAATTGGCTTATCTTTGCGGTTAGGTCTTCCATCGTAAGGTCCTTTTTGGGTCTGCCCCTGGGCGC
GGCCTTGTACAGTTCATCCATCCCAT
mCherry cassette template, Addgene 60954
mCherry KpnI-S AAAGGTACCATGGTGAGCAAGGGCGAGGAGGA
mCherry NotI-AS AAAGCGGCCGCCTACTTGTACAGCTCGTCCATGCCGCCGGTGG
Template pEPkan-S, Addgene (plasmid 41017)
mCherry-Kan PstI-S AAACTGCAGGACGGCGAGTTCATCTACAAGGTGAAGCTGCGCGGCACCAACTTCCCCTCCGAC
TAGGGATAACAGGGTAATCGATTT
mCherry-Kan PstI-AS AAACTGCAGCCAGTGTTACAACCAATTAACC
mCherry LANA N-Fw ACTGCCACCGCCTCCATAATTTTACTTTGGTTGTCAGACCAGATTTCCCGAGGATGGTGAGCAAG
GGCGAGGAGG
mCherry LANA N-Rv CCTCTCGTTAAGGGCGCGCCGGTGCTCCGTCCCGACCTCAGGCGCATTCCCGGTGGCGCACCACC
CTTGTACAGCTCGTCCATGCCGCCGGTGGAG
aRestriction enzyme sites used for cloning are underlined. Italics indicate homology arms for recombination. Boldface indicates sequence annealed to cloned
fluorescent coding sequence for amplification DNA fragment for recombination.
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peripherally distributed, just inside the nuclear membrane or surrounding the nucleoli
(Fig. 4), and were relatively immobile over the course of live cell imaging. However,
those LANA dots started to diffuse after triggering reactivation (Fig. 3A). At 24 h after
stimulation, mBFP-ORF6 became visible and some mBFP-ORF6 showed unique puncta,
while others showed very bright spots. The bright dot-like structures were not a result
of the accumulation of multiple smaller puncta; the time lapse showed that the
mBFP-ORF6 dots appeared as dots from the beginning (Fig. S2). The LANA dots and
mBFP-ORF6 did not colocalize with each other. At 48 h postinduction, mCardinal-ORF52
became visible and was expressed primarily in the cytoplasm. Strong signals of
mCardinal-ORF52, however, did not correlate with the presence of brighter mBFP2
signals (Fig. 3A). The mCardinal-ORF52 signal intensities gradually increased, while both
LANA dots and mBFP2-ORF6 signals were usually absent from those ORF52-positive
cells (Fig. 3A, row for 72 h). Where specific antibodies were available to us, immuno-
blotting or immunofluorescence staining confirmed the identity of the fusion proteins.
mCardinal-ORF52 protein was detected as an approximately 40-kDa protein in both
ORF52 and RFP antibodies (Fig. S3A). The distribution of mCherry fluorescence also was
directly correlated with LANA antibody staining (Fig. S3B). These results indicate that
tagged fusion proteins were not cleaved and indeed were intact. K-Rta expression and
expression of another early protein (K8) were used to mark reactivating cells by
immunofluorescence staining at 24 h before the majority of mCardinal-ORF52 expres-
sion. Because of exogenous K-Rta expression from the tet-inducible cassette, K-Rta was
present in every cell, while a few cells showed stronger signals. This is presumably due
to additional K-Rta expression from Rainbow-KSHV genomes (Fig. 3B). K8 expression
was present only in mBFP-ORF6-positive cells, ensuring mBFP2-positive cells are the
reactivating cells (Fig. 3B).
FIG 1 Schematic diagram of procedures to prepare Rainbow-KSHV. (i) The cDNA of fluorescence tag coding sequence (mBFP2, mCardinal, or mCherry) first was
cloned into pBS vector. (ii and iii) The kanamycin cassette with I-SceI recognition sequence along with 50-bp homology sequence was amplified by PCR and
cloned into the indicated unique restriction enzyme site (AccI or PstI). (iv and v) The resulting plasmid was used as a template to generate a DNA fragment
for homologous recombination with BAC16 inside bacteria. (vi and vii) After confirmation of insertion at the correct site by colony PCR screening, the kanamycin
cassette was deleted by recombination after induction of I-SceI in bacteria by L-arabinose. Correct insertion of the fluorescence tags and integrity of BAC DNA
were confirmed by sequencing of PCR-amplified fragments and restriction digestions. (viii and ix) Additional viral proteins were similarly tagged with mCherry
and mCardinal fluorescent protein. Primers and DNA fragment used are listed in Table 1.
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Subcellular localization of KSHV episomes and KSHV replication compartments
in the host cell nucleus. To better understand how KSHV episomes reorganize during
reactivation to form viral replication compartments inside the host cell nucleus, we
visualized nuclear membrane and nucleoli by labeling lamin A/C and nucleolin, respec-
tively. Fluorescence-labeled KSHV episomes were frequently observed in proximity to
these structures but never directly on the nuclear membrane or in nucleoli (Fig. 4A and
B). During reactivation, mBFP2-ORF6, which is associated with KSHV replication com-
partments, appeared to accumulate around nucleoli and partially colocalize with
nucleolin (Fig. 4B). The nucleolus structure also was disrupted in mBFP2-positive cells,
and nucleolin appeared to leak into the nucleoplasm (Fig. 4A, bottom, 0 h versus 24 h).
High-magnification three-dimensional (3D) images showed the invasion of nucleoplas-
mic space by the mBFP2-ORF6 protein (Fig. 4B).
Studying reactivation kinetics in cell populations at single-cell resolution. We
next monitored KSHV reactivation by flow cytometry. iSLK-Rainbow was induced with
doxycycline and TPA for 8 h, and cells were harvested at 24-h intervals for 3 days. The
proportion of fluorescent-positive cells, fluorescence intensities, and their color com-
FIG 2 Viral gene expression and production of progeny virus. (A) Viral gene expression. Rainbow-KSHV-infected iSLK cells were stimulated with doxycycline and
TPA. Total RNAs were purified at the indicated time points and subjected to KSHV PCR arrays. Gene expression is shown as a heatmap. 18S rRNA was used as
an internal standard for normalization, and the 0-h time point was set as 1. (B) Viral protein expression. Total cell lysates were prepared at the indicated time
points and subjected to immunoblotting. KSHV proteins and -actin protein were probed with specific antibodies. WB, Western blotting. (C) Production of
progeny virus. Capsidated viral DNA copy number was quantified by quantitative PCR 96 h poststimulation. (D) mCardinal fluorescence during initial infection.
The indicated DNA copy numbers of virions were infected into iSLK cells, and the mCardinal-positive cell population was quantified with FACS at 4 h after
infection. (E) De novo infection. The indicated DNA copy numbers of virions were infected into iSLK cells, and the GFP-positive cell population was quantified
with FACS 48 h after infection. (F) Electron micrograph of viral particle. KSHV viral particles in reactivated cells (left and middle) and purified from tissue culture
supernatant (right) were visualized by electron microscopy.
Nakajima et al. Journal of Virology
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binations in reactivating cells were monitored. As shown in Fig. 5, intensity and number
of mBFP-positive cells were strongly increased at 24 h, further increased until 48 h, and
then declined by the 72-h time point. The mCardinal signals gradually accumulated at
24 h and reached the highest number and intensity at 48 h. The signal then stayed at
similar levels until the end of the time period. Considering that a fraction of cells died
off and were eliminated from the analyses by a gating strategy (Fig. S4), the result
suggested that mCardinal-ORF52, but not mBFP-ORF6, continued to express and
maintained a proportion of positive cells between 48 and 72 h. The LIVE/DEAD staining
confirmed that approximately 30% of cells died in the first 24 h of reactivation,
FIG 3 (A) Expression and localization of mCherry-LANA, mBFP-ORF6, and mCardinal-ORF52. iSLK cells
latently infected with Rainbow-KSHV were stimulated with doxycycline and TPA for 0, 24, 48, and 72 h.
The cells were fixed with 4% paraformaldehyde. Fluorescence protein-tagged viral proteins were
visualized by fluorescence microscopy. BF, bright field. (B) K-Rta and K8 protein expression in Rainbow-
KSHV-infected iSLK cells. Cells were fixed at 24 h after reactivation, and K8 and K-Rta were stained with
specific antibody. Because most cells do not express mCardinal-ORF52 at the 24-h time point, we used
Alexa647-conjugated secondary antibody for visualization of K-Rta and K8 proteins.
Reporter KSHV for Single-Cell Studies Journal of Virology
April 2020 Volume 94 Issue 8 e01565-19 jvi.asm.org 7
presumably due to the toxicity of the stimuli (Fig. S5). A smaller fraction of the cell
population was positive for both mBFP2 and mCardinal (5.0%) than of cells expressing
either mBFP (16.5%) or mCardinal alone (25.8%) at 72 h (Fig. 5B), suggesting rapid
elimination of mBFP2-ORF6 protein in mCardinal-expressing cells. Time-lapse live im-
aging showed that approximately 10% of overall mBFP-ORF6-positive cells expressed
mCardinal-ORF52 within a 12-h time frame, indicating there is a hurdle for viral late
protein expression, at least for the amount of mCardinal visible under fluorescence
microscopy. At the same time, small numbers of cells rapidly expressed mCardinal in
fewer than 24 h (Fig. 5A and B). These results suggested a wide range of kinetics of
KSHV gene expression and DNA replication at the individual cell level. Even though
most LANA dots appeared to diffuse after 24 h of reactivation (Fig. 3), the overall
mCherry signal intensity in each cell was relatively unchanged (Fig. 5C), suggesting
LANA was dissociated from the TR sequence and diffused to the nucleoplasm without
degradation. Similar kinetics and phenotypes were also seen in 293FT cells, albeit at
much lower rates of reactivation (Fig. S6).
Inhibition of mBFP2-ORF6 gene expression in the presence of mCardinal-
ORF52. The schematic presented in Fig. 6A shows our strategy of cell fractionation.
KSHV PCR arrays were employed to analyze KSHV gene expression for each of the cell
pools, and selected viral genes with different kinetics were shown (Fig. 6B). As ex-
pected, isolating reactivating cells from nonresponders increased dynamic ranges of
viral gene expression approximately 5- to 10-fold. Isolation of cells most strongly
lowered CT values of late genes; this likely reflects the smaller proportion of late
gene-expressing cells in the cell population. Interestingly, a cell fraction (mCard/
mBFP) showed very little late gene expression despite the presence of mCardinal
protein, indicating late gene expression occurs very transiently and happens sponta-
neously with viral DNA replication. The largest amount of late gene expression was
indeed seen in the double-positive cell fraction (mCard/mBFP2). With fractionation,
we also observed clear downregulation of most of the viral genes in the mCardinal/
mBFP cell fraction. The inclusion of proteasome or lysosomal inhibitors did not
FIG 4 Spatial association of KSHV episome with nucleoli and nuclear envelope. (A) Immunofluorescence staining. Nuclear structure was visualized by
immunofluorescence staining of lamin A/C and nucleolin in Rainbow-KSHV-infected iSLK cells at the indicated time points after stimulation. (B) 3D
reconstruction of images. The Z-stack images were reconstructed as 3D images with Volocity software. After 24 h of stimulation, mBFP-ORF6 expression (blue)
appears to fill the interchromosomal space surrounding the host cell nucleoli, marked by antinucleolin staining (greyscale).
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recover mBFP2 expression in the mCardinal-positive fraction, suggesting that down-
regulation of mBFP2 was primarily at transcriptional levels (Fig. S7). Downregulation of
early genes in mCardinal-positive cells was further confirmed by RNA-fluorescent in situ
hybridization (FISH) with PAN RNA probes. Strong PAN RNA signals (red) were observed
mostly in the mBFP-ORF6-positive cells (blue). Consistent with quantitative PCR
(qPCR) results, mCardinal-positive cells (yellow) showed much lower intensities of PAN
RNA signals (Fig. 6C and Fig. S8). Of note, the RNA-FISH signal of PAN RNA was
extremely strong, so the exposure time for the red channel was set to 1/100 s. With this
setting, we avoided having overlapping signals from mCherry-LANA, which requires a
minimum of 0.5 s of exposure with the same setting. Although differences of cellular
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression among three groups
(blue, brown, and purple; mBFP- and/or mCardinal-positive fractions) were statistically
significant (P 0.01), those fold changes were much smaller (less than 1.5 times) than
those of viral lytic genes in the mCardinal-positive fraction, especially in the mCardinal-
only group (Fig. 6B and C, purple bars). Similar regulation was not seen in LANA
expression. The result suggests the presence of a specific molecular mechanism to
regulate inducible lytic gene expression. We also confirmed higher numbers of intra-
cellular viral DNA copies in the mBFP-positive cell fraction at 24 h (Fig. 6E). These results
together demonstrated increased resolution of analyses.
DISCUSSION
Genetic and molecular heterogeneity in cells of the same tissue type and lineage has
become increasingly evident through advanced single-cell omics (43, 44). Whether it
originates from spontaneous changes in gene expression or stochastic responses to
environmental perturbations, this inherent heterogeneity limits the potential efficacy of
targeted therapeutics. Similarly, in our research, we believe that molecular heteroge-
neity accounts for the wide range of responses to KSHV reactivation stimulation. It has
been known that lytic proteins, particularly those of late genes, are not uniformly
expressed, even after strong stimulation by K-Rta and TPA treatment. We would like to
FIG 5 Flow cytometry analysis of Rainbow-KSHV-infected cells. (A) Profile of mBFP-ORF6 and mCardinal-ORF52 expression after stimulation. iSLK cells infected
with Rainbow-KSHV were stimulated with doxycycline and TPA. The cells were fixed with 2% paraformaldehyde at the indicated time point, and expression of
GFP, mCherry-LANA, mBFP-ORF6, and mCardinal-ORF52 was analyzed by flow cytometry. Gating strategies are summarized in the supplemental material (Fig.
S4). (B) Combination of fluorescence. Percentages of cell populations with fluorescence-positive and -negative cells are shown in the bar chart. (C) Mean
intensities of each fluorescence protein. Changes of mean intensities were calculated. Fluorescence intensity at the 0-h time point was set to 1.
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understand the differences that lead some cells to respond and others to be nonre-
sponders or abortive responders under the same experimental conditions. However, it
is practically impossible to use conventional methods to identify molecular mecha-
nisms when samples inevitably contain mixtures of cells exhibiting these different
behaviors. Therefore, we developed Rainbow-KSHV as a tool for visualization and spot
determination of the KSHV reactivation stage in live host cells.
Recent single-cell transcriptome analysis techniques have indeed revealed that viral
infection and replication is highly heterogeneous, with only a small fraction of infected
cells producing the bulk of progeny virus. Russell et al. recently reported that there is
extremely large cell-to-cell variation in the production of transcription in influenza
virus-infected cells (45). Similar transcriptional heterogeneity was also reported in
HSV-1-infected cells (46). In KSHV infection, several reports demonstrated abortive
infection, in which only selected viral genes are expressed temporally and do not
produce viral particles. Infection of nonpermissive primary cells or deletion of the K8
gene from the KSHV genome also led to abortive infection (47, 48). In addition, one of
the key cellular factors required for the completion of KSHV replication in B cells has
been identified. CBF1/CSL, which plays a role in stronger and/or continuous induction
of lytic gene expression, is essential for completion of KSHV replication, and deletion of
the host gene from B cells led to abortive infection (49). These studies clearly suggest
FIG 6 Fractionation of reactivated cells from nonresponding cells. (A) Reactivated cell fractions by color codes. Reactivated cells were fractionated with FACS
into four populations: (i) mBFP mCardinal, (ii) mBFP mCardinal, (iii) mBFP mCardinal, and (iv) mBFP mCardinal. (B) Heterogenic viral gene expression
at a given time point. Total RNA was extracted from fractionated cells, and expression of latent, immediate-early, early, and late lytic genes was assessed by
real-time qPCR and shown as bar graphs. 18S rRNA was an internal standard for normalization. Black, red, gray, blue, orange, and purple columns represent
0-h presort, 48-h presort, 48-h mBFP mCardinal, 48-h mBFP mCardinal, 48-h mBFP mCardinal, and 48-h mBFP mCardinal, respectively. ANOVA
followed by Tukey’s test was performed for 48-h mBFP mCardinal, 48-h mBFP mCardinal, and 48-h mBFP mCardinal. *, P 0.05. **, P 0.01. (C)
Expression of PAN RNA. PAN RNA expression was examined with real-time qPCR (a) and RNA-FISH (b). Red, PAN RNA; blue, mBFP2-ORF6; yellow,
mCardinal-ORF52. ANOVA followed by Tukey’s test was performed for 48-h mBFP mCardinal, 48-h mBFP mCardinal, and 48-h mBFP mCardinal. **,
P 0.01. NS, not significant. (D) Expression of mCherry and GAPDH at a given time point. (E) Heterogenic viral DNA replication. iSLK cells latently infected with
Rainbow-KSHV were stimulated with doxycycline and TPA for 24 h. Cells were fractionated by FACS into two populations: BFP (i) and BFP (ii). DNA was
purified from each cell fraction, and viral DNA copy number was determined by real-time qPCR. **, P 0.01.
Nakajima et al. Journal of Virology
April 2020 Volume 94 Issue 8 e01565-19 jvi.asm.org 10
completion of KSHV replication hinges on fine balances of the degree of activation of
viral genomes (e.g., viral DNA episome numbers, amount of K-Rta protein expression
via strength, duration of K-Rta promoter activation, and presence of cellular cofactors/
activator) (24, 50–52) and condensation of KSHV genomes by the viral and host factors
(53–56). Higher resolutions of analyses will be increasingly important to identify
host/viral factors associated with such outcomes.
It is important to note that Brulois et al. previously generated a similar reporter
construct, named RGB-BAC16 (red-green-blue-BAC16). In this reporter virus, expression
of mRFP1 (red), EGFP (green), and tagBFP (blue) was placed under the control of
constitutively active EF1, a PAN RNA promoter, and a K8.1 promoter, respectively (57).
Differences between our reporter construct and the RGB-BAC16 are that (i) the expres-
sion of fusion proteins from the endogenous corresponding promoters is expected to
report viral gene expression more closely resembling that of the natural settings of viral
replication, (ii) latent viral copy number in each infected cell can be measured by
counting LANA dots in the nucleus, (iii) the establishment of a viral replication com-
partment may be visualized in live cells with mBFP-ORF6 fluorescence, which is directly
associated with KSHV DNA replication, and (iv) fluorescence intensity directly correlates
with the amount of corresponding viral protein in the cells. Nonetheless, the RGB-
BAC16 has been used widely in many laboratories with great success (30, 58–60), and
we are hopeful that Rainbow-KSHV will become an important complement.
During the course of our studies, we realized that iSLK cells produced the largest
amount of DNase I-resistant viral DNA; however, we also noticed that a higher viral DNA
copy number in culture media did not always correspond to a higher infection rate after
de novo infection. Based on our detection and measurement of mCardinal fluorescence,
we think only a small fraction of cells produce viral particles, and of these, an even
smaller subpopulation are generating infectious particles in the culture supernatant. It
is interesting to determine specific cell types and tissue culture conditions that favor
producing more infectious viral particles in the supernatant; single-cell analyses with
proteomics approaches may help to answer the question.
The unique staining pattern of mBFP2-ORF6, particularly in relation to that of
nucleolin, a protein maker for the nucleolus, is interesting and possibly significant. The
nucleolus has the most active cellular transcription site in the nucleus but also has an
attractive compartment for nuclear heterochromatic regions, such as pericentric re-
peats and regions enriched in repressed genes with low gene density (61, 62). Thus, the
nuclear space is the region for the coexistence of euchromatic and heterochromatic
rRNA genes. Interestingly, cytomegalovirus UL84 and UL44 proteins have been shown
to interact with nucleolin and play a role in the formation of viral replication compart-
ments near the nucleoli (63, 64). For EBV, EBNA1 interacts with nucleolin, while the RNA
binding domain of nucleolin plays a critical role in EBV episome maintenance (65). We
recently found that KSHV episomes preferentially tether near the centromere of the
host chromosome and other nucleolus-associated chromosomal domains (66 and M.
Campbell and Y. Izumiya, unpublished observations). We postulate that the unique
nuclear environment is suitable for establishment/maintenance as well as reactivation
of KSHV after stimulation.
Another notable finding is that small cell populations support KSHV replication very
well. About 4% of iSLK cells have shown mCardinal signals at the 24-h time point. In
light of HSV-1 replication kinetics with a high multiplicity of infection (MOI), it is not
surprising that KSHV can replicate in a short period of time. The result is also consistent
with quantitative reverse transcription-PCR (qRT-PCR) array studies that have shown
lowered CT values of late genes 24 h postactivation (Fig. 2A). What makes the cellular
environment ideal for viral replication requires further investigation. In HSV-1 studies
with ICP0 mutant virus, it was demonstrated that there is a threshold at which the
mutant virus can replicate normally (67). Those studies indicated that increased MOI
overcame defects of the mutations. A cell with robust induction of KSHV gene expres-
sion may enter KSHV replication, while other cells might need extra time to accumulate
viral transcriptional factors to pass a certain threshold. The activity of specific transcrip-
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tional factors in the cell or epigenetic gene modifications, including a genomic struc-
ture, are likely the key factors for efficient RNA polymerase II recruitment. In addition,
a high latent episome copy number likely would increase the chance of producing a
higher yield. By counting LANA dots in a 3D nucleus, we also noticed that the KSHV
episome number changed with every cell division, which also may be associated with
the heterogenic responses to the stimuli. Combinations of mBFP2-ORF6 also can offer
information for when, in which cells, and where in the nucleus KSHV starts to replicate.
We think this Rainbow-KSHV is an especially powerful tool for analyzing the association
of KSHV replication with cellular differentiation in a 3D organotypic culture system or
organoid tissue culture models.
By fractionating infected cells by replication stages, we could demonstrate clear
temporal viral gene regulation. KSHV lytic gene expression was strongly diminished in
the mCardinal/mBFP2 cell fraction. Interestingly, such downregulation was more
clearly seen in lytic genes (mostly early and late genes). More late gene transcripts in
the mBFP2-positive fractions than mBFP2-negative cell population also suggests tran-
sient late gene expression in mBFP2-positive (DNA-replicating) cells. Late gene expres-
sion in the double-positive (mBFP2/mCardinal) cell fraction showed a CT value
comparable to that of immediate-early and early genes. Accordingly, seemingly lower
level of expression of late genes in previous studies likely was due to lower cell
numbers within the cell population that successfully entered late viral replication
stages, as well as the shorter window of their expression kinetics. Finally, we are hopeful
that our Rainbow-KSHV contributes to rapidly developing single-cell approaches and
further advances our understanding of KSHV replication cycles. With single-cell genom-
ics and proteomics approaches with Rainbow-KSHV, we may be able to probe key
activators and/or more of the restriction factors for KSHV replication in the near future.
MATERIALS AND METHODS
Chemicals. Dulbecco’s modified minimal essential medium (DMEM), fetal bovine serum (FBS),
phosphate-buffered saline (PBS), Trypsin-EDTA solution, 100 penicillin–streptomycin–L-glutamine so-
lution, anti-RFP antibody, Alexa 647-conjugated secondary antibody, SlowFade Gold antifade reagent,
and a LIVE/DEAD fixable yellow dead cell stain kit were purchased from Thermo Fisher (Waltham, MA
USA). Puromycin solution and G418 solution were obtained from InvivoGen (San Diego, CA, USA).
Hygromycin B solution was purchased from Enzo Life Science (Farmingdale, NY, USA). Anti-ORF57,
anti-K8, and anti-K8.1 antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA,
USA). Anti-LANA and anti-lamin A/C antibodies were purchased from Millipore-Sigma (St. Louis, MO,
USA). Anti-nucleolin antibody was purchased from Abcam (Cambridge, UK). Anti-K-Rta antibody was
described previously (68). Monoclonal anti-ORF52 antibody was a generous gift from Fanxiu Zhu (Florida
State University). All other chemicals were purchased from Millipore-Sigma (St. Louis, MO, USA) unless
otherwise stated.
Cell culture. iSLK.219 cells were maintained in DMEM supplemented with 10% FBS, 10 g/ml
puromycin, 400 g/ml hygromycin B, and 250 g/ml G418. iSLK cells were obtained from Don Ganem
(Novartis Institutes for Biomedical Research). 293 (ATCC, Manassas, VA, USA) and 293T (ATCC, Manassas,
VA, USA) cells were grown in DMEM containing 10% FBS.
Construction of Rainbow-KSHV BAC16. Recombinant KSHV was prepared by following a protocol
for en passant mutagenesis with a two-step markerless red recombination technique (69). Briefly,
fluorescence protein-coding sequences first were cloned into a pBS SK vector (Thermo Fisher, Waltham,
MA, USA) after amplifying cDNA from the respective plasmid as templates, obtained from Addgene
(Table 1). The pEPkan-S plasmid was also used as a source of the kanamycin cassette, which includes the
I-SecI restriction enzyme site at the 5= end of the kanamycin coding region (69). The kanamycin cassette
was amplified with primer pairs listed in Table 1. An amplified kanamycin cassette then was cloned into
the fluorescence protein-coding region at a unique restriction enzyme site (e.g., AccI for mBFP2 and
mCardinal, PstI for mCherry). The resulting plasmid was used as a template for another round of PCR to
prepare a transfer DNA fragment for markerless recombination with BAC16 (22). Recombinant BAC clones
with insertion and also deletion of the kanamycin cassette in the BAC16 genome were confirmed by
colony PCR with appropriate primer pairs. Recombination junctions and adjacent genomic regions were
amplified by PCR, and the resulting PCR products were directly sequenced with the same primers to
confirm in-frame insertion into the BAC DNA. The resulting recombinant BAC was also confirmed by
restriction enzyme digestions (HindIII and BglII) if there were any large DNA deletions. Two independent
BAC clones were generated for each fluorescence-tagged recombinant virus as biological replicates.
Western blotting. Cells were lysed in immunoprecipitation lysis buffer (25 mM Tris-HCl, pH 7.4,
150 mM NaCl, 1% NP-40, 1 mM EDTA, 5% glycerol) containing protease inhibitors (Roche, Basel, Swit-
zerland). Total cell lysates (25 g) were boiled in SDS-PAGE loading buffer, subjected to SDS-PAGE, and
subsequently transferred to a polyvinylidene fluoride membrane (Millipore-Sigma, St. Louis, MO, USA)
using a semidry transfer apparatus (Bio-Rad, Hercules, CA, USA). The final dilution of the primary antibody
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was 1:5,000 for anti-K-Rta rabbit serum, 1 g/ml anti-K8 (Santa Cruz, Santa Cruz, CA, USA), 1 g/ml
anti-ORF57 mouse monoclonal antibody (Santa Cruz, Santa Cruz, CA, USA) and anti-LANA rat monoclonal
(Millipore-Sigma, St. Louis, MO, USA), 1 g/ml anti-K8.1 mouse monoclonal (Santa Cruz, Santa Cruz, CA,
USA), 1:1,000 anti-RFP monoclonal antibody (Thermo Fisher), 1:500 anti-ORF52 monoclonal antibody, and
1:5,000 anti--actin mouse monoclonal (Millipore-Sigma, St. Louis, MO, USA). Washing membranes and
secondary antibody incubations were performed as described previously (50).
Immunofluorescence microscopy and 3D image analysis. iSLK cells latently infected with
Rainbow-KSHV were seeded onto glass coverslips 20 to 24 h before stimulation. The cells then were
stimulated with 1 g/ml doxycycline and 20 ng/ml 12-O-tetradecanoylphorbol 13-acetate (TPA) for 0, 24,
48, and 72 h. The stimulated cells were fixed with 4% paraformaldehyde, permeabilized with 0.2% Triton
X-100 in PBS, and incubated with 2% bovine serum albumin (BSA) in PBS to block nonspecific antibody
binding. The cells then were treated with the primary antibody followed by fluorescent dye-conjugated
secondary antibody. Cell imaging was performed on a Keyence BZ-X700 inverted microscope (Keyence,
Osaka, Japan). Fluorophores and filters used in this study are summarized in Table 2. All filters were
purchased from Chroma Technology Co. (Bellows Falls, VT, USA). For 3D visualization and analysis, Z stack
image data were converted to greyscale in TIF format and imported to Volocity (Quorum Technologies,
Inc., ON, Canada). Fluorophores and filters used in this study are summarized in Table 2.
RNA-FISH. iSLK cells infected with Rainbow-KSHV were seeded onto glass coverslips and reactivated
with 1 g/ml doxycycline and 20 ng/ml TPA for 48 h. Cells were fixed with 4% formaldehyde–PBS.
Coverslips were incubated with 100 mM glycine-PBS for 10 min and washed with PBS three times in a
6-well plate. Cells were treated with 0.2% Triton-X and 0.05% SDS for 10 min and subsequently washed
with FISH wash buffer (10% formamide [Millipore-Sigma, St. Louis, MO, USA], 2 SSC [1 SSC is 0.15 M
NaCl and 0.015 M sodium citrate]) three times. PAN RNA FISH probes were hybridized on glass slides in
hybridization buffer (10% dextran sulfate, 100 g/ml yeast tRNA [Millipore-Sigma, St. Louis, MO, USA],
10% formamide, 125 nM FISH probe) overnight at 37°C. Cover slips were washed with FISH wash buffer
and mounted with SlowFade Gold antifade reagent. Probe sequences are listed in Table 3 and were
obtained from LGC Biosearch Technologies (Teddington, UK). More detailed step-by-step methods were
published previously (70).
Quantification of viral copy numbers. Two hundred microliters of cell culture supernatant was
treated with 12 g/ml DNase I for 15 min at room temperature to degrade DNAs that are not correctly
encapsidated. This reaction was stopped by the addition of EDTA to 5 mM, followed by heating at 70°C
for 15 min. Viral genomic DNA was purified using a QIAamp DNA minikit according to the manufacturer’s
protocol and eluted in 100 l of AE buffer. Two microliters of eluate was used for real-time qPCR to
determine viral copy number, as described previously (50).
Preparation of purified KSHV. iSLK cells latently infected with Rainbow-KSHV were seeded in eight
to ten 15-cm dishes, stimulated with 1 g/ml doxycycline and 20 ng/ml TPA for 24 h, and further
incubated with culture media without stimuli for 72 h. The culture supernatant was centrifuged using a
Beckman SW28 rotor (25,000 rpm for 2 h) with a 25% sucrose cushion. Virus pellet was dissolved in DMEM
and further purified by discontinuous sucrose gradient (25 to 60%) centrifugation using a Beckman
SW40Ti rotor (21,000 rpm, for 16 h). The virus pellet was dissolved in DMEM (for infection) or in water (for
electron microscopy). Viral copy number was determined by real-time qPCR as described elsewhere.
Real-time RT-PCR. Total RNA was isolated using a quick RNA miniprep kit (Zymo Research, Irvine, CA,
USA). First-strand cDNA was synthesized using a high-capacity cDNA reverse transcription kit (Thermo
Fisher, Waltham, MA USA). Gene expression was analyzed by real-time qPCR using specific primers for
KSHV ORFs designed by Fakhari and Dittmer (71). We used 18S rRNA as an internal standard to normalize
viral gene expression.
FACS analysis. iSLK cells latently infected with Rainbow-KSHV were seeded in 6-cm dishes and
stimulated with 1 g/ml doxycycline and 20 ng/ml TPA for 0, 24, 48, and 72 h. Stimulated cells were fixed
with 2% paraformaldehyde and suspended in 1% BSA in PBS. Samples were acquired on an Attune flow
cytometer (Thermo Fisher, Waltham, MA USA) and analyzed with FlowJo software (BD Bioscience, San
Jose, CA, USA). For live/dead fluorescence-activated cell sorting (FACS) analysis, stimulated cells were
stained with LIVE/DEAD fixable yellow dead cell stain kit according to the manufacturer’s protocol. The
cells then were fixed and analyzed as described above.
Alternatively, 293FT cells infected with Rainbow-KSHV were seeded in 6-cm dishes and stimulated
with 1.5 mM sodium butyrate and 20 ng/ml TPA for 0, 24, 48, and 72 h. Stimulated cells were fixed and
analyzed with a flow cytometer as described above.
Cell fractionation using FACS. iSLK cells harboring Rainbow-KSHV were seeded in 10-cm dishes and
stimulated with 1 g/ml doxycycline and 20 ng/ml TPA for 0, 24, and 48 h. Cells were trypsinized and
suspended in 1% BSA in PBS. Cell fractionation was performed using a MoFlo Astrios EQ cell sorter
TABLE 2 Fluorophores and filters used in this study
Fluorophore Excitation (nm) Emission (nm) Filter (nm; excitation, emission)
EGFP 488 507 470/40, 525/50
mCherry 587 610 545/25, 605/70
mTagBFP2 399 454 360/40, 460/50
mCardinal 604 659 640/30, 700/75
Alexa 647 650 670 640/30, 700/75
Quasar 570 548 570 545/25, 605/70
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(Beckman Coulter, Indianapolis, IN, USA) or InFlux cell sorter (Becton, Dickinson, Franklin Lakes, NJ) for
subpopulations based on fluorescence codes. DNA or total RNA was extracted using a QIAamp DNA
minikit (Qiagen, Venlo, Netherlands) or quick-RNA miniprep kit (Zymo Research, Irvine, CA, USA),
respectively, immediately after cell fractionation.
Electron microscopy. Isolated virions were visualized by negative staining on TEM. Briefly, small
droplets (10 l) of purified KSHV in water were placed on 400-mesh copper grids with Formvar/carbon
support film (Ted Pella, Inc., Redding, CA, USA) and left in a dust-free environment for 10 min. After
wicking off the excess moisture with filter paper, 10 l of 2% uranyl acetate in distilled H2O was added
to the grid and immediately removed (again by wicking with filter paper). Grids were allowed to air dry
completely before viewing by transmission electron microscopy (FEI Talos L120C equipped with an
integrated Ceta CMOS camera; Thermo Fisher, Waltham, MA USA) at 100 kV.
iSLK cells latently infected with Rainbow-KSHV were stimulated with 1 g/ml doxycycline and
20 ng/ml TPA for 72 h. Cells were collected and fixed in modified Karnovsky solution containing 2.5%
glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium phosphate buffer. Cells were subsequently
rinsed twice in 0.1 M NaH2PO4 for a total of 30 min and resuspended in 0.1 M NaH2PO4 containing 1%
osmium tetroxide and 1.5% potassium ferrocyanide for 45 min. Cells again were rinsed twice with 0.1 M
NaH2PO4 for 30 min and successively dehydrated in 50% ethanol (EtOH), 75% EtOH, 95% EtOH (30 min
each), and finally in 100% EtOH (twice for 30 min each time). Propylene oxide (two 15-min washes) was
used as a transitional solvent. Cells then were preinfiltrated overnight at a 50:50 ratio propylene oxide
to resin (composed of 450 ml dodecenyl succinic anhydride, 250 ml araldite 6005, 82.5 ml Epon 812,
12.5 ml dibutyl phthalate, and 450 l benzyldimethylamine). The following day, cells were infiltrated with
100% resin for 5 h and subsequently embedded in fresh resin. The embedded cells were sectioned with
an ultramicrotome at a thickness of 90 nm and collected on copper mesh grids. The sections were stained
with 4% aqueous uranyl acetate for 30 min and for 2 min in 0.2% lead citrate in 0.1 N NaOH. Finally,
samples were washed and allowed to dry before imaging again on the FEI Talos 120C transmission
electron microscope.
Statistical analysis. Results are shown as means  standard deviations from at least three inde-
pendent experiments. Data were analyzed using unpaired Student’s t test or analysis of variance (ANOVA)
followed by Tukey’s honestly significant difference test. A P value of 0.05 was considered statistically
significant.
TABLE 3 RNA-FISH probe sequence for PAN RNAa
Probe Sequence
PAN RNA probe_1 AAGAAGGCAAGCAGCGAGCA
PAN RNA probe_2 CGGCACCAATGAAAACCAGA
PAN RNA probe_3 GACGCAATCAACCCACAATC
PAN RNA probe_4 CAGGATGGGTATATTGCCAA
PAN RNA probe_5 GACGGAGAACCTAGCCGAAA
PAN RNA probe_6 CAGGCCAATGTGGGAAAAGT
PAN RNA probe_7 GCGGTGTTTTTTGTACTACA
PAN RNA probe_8 TTTTGTTCTGCGGGCTTATG
PAN RNA probe_9 AGGTTTTTGGGCAAATCGCA
PAN RNA probe_10 TGACTGTATAGTTGCCATGG
PAN RNA probe_11 CAATGCAATAACCCGCAAGG
PAN RNA probe_12 CAACTGGCCTGGAGATTGAA
PAN RNA probe_13 CGCATATCATAAAAGGGGGC
PAN RNA probe_14 TCCACATTCAGACACGTTAA
PAN RNA probe_15 CTGCTTTCCTTTCACATTAT
PAN RNA probe_16 ACTGTTCTGATACACCAGTG
PAN RNA probe_17 ATGAGCAGATAGGTAGTGCA
PAN RNA probe_18 TCAGACAAACACAGAACCGA
PAN RNA probe_19 ATCCGCTTTCTAGAATTACC
PAN RNA probe_20 CAAAGTGGCCCGATTTACAC
PAN RNA probe_21 ACACATCCAGATTGTCACAT
PAN RNA probe_22 AAATGCTTCACAACGCACCA
PAN RNA probe_23 ATTACAGCACTAGCCTGATA
PAN RNA probe_24 GTCATTCAAATCGACTTGCT
PAN RNA probe_25 GAAACTTCTGACAAATGCCA
PAN RNA probe_26 CACACCACTTTAGTCCAATG
PAN RNA probe_27 AACATTGAAAGAGCGCTCCC
PAN RNA probe_28 ACATCGTTAGTCAACCTAGC
PAN RNA probe_29 CACAACGCTTTCACCTACAA
PAN RNA probe_30 CAGCCAAAACACCGTTATCA
PAN RNA probe_31 GTCCGGTGCGAACAAGGAAA
PAN RNA probe_32 TGAGCTCTAGGCACGTTAAA
PAN RNA probe_33 AGTTGCATTACGTTATGGTA
aAll oligonucleotides were labeled with Quasar 570 and pooled for RNA-FISH.
Nakajima et al. Journal of Virology
April 2020 Volume 94 Issue 8 e01565-19 jvi.asm.org 14
SUPPLEMENTAL MATERIAL
Supplemental material is available online only.
SUPPLEMENTAL FILE 1, PDF file, 7.2 MB.
ACKNOWLEDGMENTS
We thank Yuichi Yanagihashi and Kazushi Nakano (Lifematics, Osaka, Japan) for
preparing heat maps. We also thank Fanxiu Zhu (Department of Biological Science,
Florida State University, Florida) for providing us with anti-ORF52 antibody.
This research was supported by Public Health Service grants from the National
Cancer Institute (CA225266, CA232845), the National Institute of Dental and Cranio-
facial Research (DE025985), and the National Institute of Allergy and Infectious Diseases
(AI147207) to Y.I. This project was also supported by the University of California Davis
Flow Cytometry Shared Resource Laboratory, with funding from NCI P30 CA0933730
and NIH NCRR C06-RR1264 to Bridget McLaughlin and Jonathan Van Dyke.
REFERENCES
1. Marioni JC, Arendt D. 2017. How single-cell genomics is changing evo-
lutionary and developmental biology. Annu Rev Cell Dev Biol 33:
537–553. https://doi.org/10.1146/annurev-cellbio-100616-060818.
2. Chattopadhyay PK, Winters AF, Lomas Iii WE, Laino AS, Woods DM. 2019.
High-parameter single-cell analysis. Annu Rev Anal Chem 12:411–430.
https://doi.org/10.1146/annurev-anchem-061417-125927.
3. Finn EH, Pegoraro G, Brandao HB, Valton AL, Oomen ME, Dekker J, Mirny
L, Misteli T. 2019. Extensive heterogeneity and intrinsic variation in
spatial genome organization. Cell 176:1502–1515. https://doi.org/10
.1016/j.cell.2019.01.020.
4. Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. 2018. Integrating
single-cell transcriptomic data across different conditions, technologies,
and species. Nat Biotechnol 36:411–420. https://doi.org/10.1038/nbt
.4096.
5. Zeng T, Dai H. 2019. Single-cell RNA sequencing-based computational
analysis to describe disease heterogeneity. Front Genet 10:629. https://
doi.org/10.3389/fgene.2019.00629.
6. Zhang T, Lv J, Tan Z, Wang B, Warden AR, Li Y, Jiang H, Li H, Ding X. 2019.
Immunocyte profiling using single-cell mass cytometry reveals
EpCAM() CD4() T cells abnormal in colon cancer. Front Immunol
10:1571. https://doi.org/10.3389/fimmu.2019.01571.
7. Galli E, Hartmann FJ, Schreiner B, Ingelfinger F, Arvaniti E, Diebold M,
Mrdjen D, van der Meer F, Krieg C, Nimer FA, Sanderson N, Stadelmann
C, Khademi M, Piehl F, Claassen M, Derfuss T, Olsson T, Becher B. 2019.
GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis.
Nat Med 25:1290–1300. https://doi.org/10.1038/s41591-019-0521-4.
8. Severe N, Karabacak NM, Gustafsson K, Baryawno N, Courties G, Kfoury
Y, Kokkaliaris KD, Rhee C, Lee D, Scadden EW, Garcia-Robledo JE, Brouse
T, Nahrendorf M, Toner M, Scadden DT. 2019. Stress-induced changes in
bone marrow stromal cell populations revealed through single-cell pro-
tein expression mapping. Cell Stem Cell 25:570–583. https://doi.org/10
.1016/j.stem.2019.06.003.
9. Zhao JB, Zhang F, Guo YL. 2019. Quantitative analysis of metabolites at
the single-cell level by hydrogen flame desorption ionization mass
spectrometry. Anal Chem 91:2752–2758. https://doi.org/10.1021/acs
.analchem.8b04422.
10. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore
PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-
associated Kaposi’s sarcoma. Science 266:1865–1869. https://doi.org/10
.1126/science.7997879.
11. Ganem D. 2010. KSHV and the pathogenesis of Kaposi sarcoma: listening
to human biology and medicine. J Clin Investig 120:939–949. https://
doi.org/10.1172/JCI40567.
12. Mesri EA, Cesarman E, Boshoff C. 2010. Kaposi’s sarcoma and its associ-
ated herpesvirus. Nat Rev Cancer 10:707–719. https://doi.org/10.1038/
nrc2888.
13. Schulz TF. 2006. The pleiotropic effects of Kaposi’s sarcoma herpesvirus.
J Pathol 208:187–198. https://doi.org/10.1002/path.1904.
14. Wong EL, Damania B. 2005. Linking KSHV to human cancer. Curr Oncol
Rep 7:349–356. https://doi.org/10.1007/s11912-005-0061-6.
15. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y.
1995. In vitro establishment and characterization of two acquired
immunodeficiency syndrome-related lymphoma cell lines (BC-1 and
BC-2) containing Kaposi’s sarcoma-associated herpesvirus-like (KSHV)
DNA sequences. Blood 86:2708–2714. https://doi.org/10.1182/blood
.V86.7.2708.bloodjournal8672708.
16. Cesarman E, Knowles DM. 1999. The role of Kaposi’s sarcoma-associated
herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Semin Cancer
Biol 9:165–174. https://doi.org/10.1006/scbi.1998.0118.
17. Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU. 2003. Global
changes in Kaposi’s sarcoma-associated virus gene expression patterns
following expression of a tetracycline-inducible Rta transactivator. J Virol
77:4205–4220. https://doi.org/10.1128/jvi.77.7.4205-4220.2003.
18. Lu M, Suen J, Frias C, Pfeiffer R, Tsai MH, Chuang E, Zeichner SL. 2004.
Dissection of the Kaposi’s sarcoma-associated herpesvirus gene ex-
pression program by using the viral DNA replication inhibitor cido-
fovir. J Virol 78:13637–13652. https://doi.org/10.1128/JVI.78.24.13637
-13652.2004.
19. Okuno T, Jiang YB, Ueda K, Nishimura K, Tamura T, Yamanishi K. 2002.
Activation of human herpesvirus 8 open reading frame K5 independent
of ORF50 expression. Virus Res 90:77–89. https://doi.org/10.1016/S0168
-1702(02)00142-9.
20. Adang LA, Parsons CH, Kedes DH. 2006. Asynchronous progression
through the lytic cascade and variations in intracellular viral loads
revealed by high-throughput single-cell analysis of Kaposi’s sarcoma-
associated herpesvirus infection. J Virol 80:10073–10082. https://doi.org/
10.1128/JVI.01156-06.
21. Chen CP, Lyu Y, Chuang F, Nakano K, Izumiya C, Jin D, Campbell M, Izumiya
Y. 2017. Kaposi’s sarcoma-associated herpesvirus hijacks RNA polymerase II
to create a viral transcriptional factory. J Virol 91:e02491-16. https://doi.org/
10.1128/JVI.02491-16.
22. Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, Toth Z, Lee SH, Lee HR,
Myoung J, Ganem D, Oh TK, Kim JF, Gao SJ, Jung JU. 2012. Construction
and manipulation of a new Kaposi’s sarcoma-associated herpesvirus
bacterial artificial chromosome clone. J Virol 86:9708–9720. https://doi
.org/10.1128/JVI.01019-12.
23. Purushothaman P, Uppal T, Verma SC. 2015. Molecular biology of KSHV
lytic reactivation. Viruses 7:116–153. https://doi.org/10.3390/v7010116.
24. Aneja KK, Yuan Y. 2017. Reactivation and lytic replication of Kaposi’s
sarcoma-associated herpesvirus: an update. Front Microbiol 8:613.
https://doi.org/10.3389/fmicb.2017.00613.
25. Ellison TJ, Izumiya Y, Izumiya C, Luciw PA, Kung HJ. 2009. A comprehen-
sive analysis of recruitment and transactivation potential of K-Rta and
K-bZIP during reactivation of Kaposi’s sarcoma-associated herpesvirus.
Virology 387:76–88. https://doi.org/10.1016/j.virol.2009.02.016.
26. Ozgur S, Griffith J. 2014. Interaction of Kaposi’s sarcoma-associated
herpesvirus ORF6 protein with single-stranded DNA. J Virol 88:
8687–8695. https://doi.org/10.1128/JVI.03652-13.
27. Peng C, Chen J, Tang W, Liu C, Chen X. 2014. Kaposi’s sarcoma-
associated herpesvirus ORF6 gene is essential in viral lytic replication.
PLoS One 9:e99542. https://doi.org/10.1371/journal.pone.0099542.
28. Nandakumar D, Glaunsinger B. 2019. An integrative approach identifies
direct targets of the late viral transcription complex and an expanded
Reporter KSHV for Single-Cell Studies Journal of Virology
April 2020 Volume 94 Issue 8 e01565-19 jvi.asm.org 15
promoter recognition motif in Kaposi’s sarcoma-associated herpesvirus.
PLoS Pathog 15:e1007774. https://doi.org/10.1371/journal.ppat.1007774.
29. Li D, Fu W, Swaminathan S. 2018. Continuous DNA replication is required
for late gene transcription and maintenance of replication compart-
ments in gammaherpesviruses. PLoS Pathog 14:e1007070. https://doi
.org/10.1371/journal.ppat.1007070.
30. Brulois K, Wong LY, Lee HR, Sivadas P, Ensser A, Feng P, Gao SJ, Toth Z,
Jung JU. 2015. Association of Kaposi’s sarcoma-associated herpesvirus
ORF31 with ORF34 and ORF24 is critical for late gene expression. J Virol
89:6148–6154. https://doi.org/10.1128/JVI.00272-15.
31. Aguirre-López B, Cabrera N, de Gómez-Puyou MT, Perez-Montfort R,
Gómez-Puyou A. 2017. The importance of arginine codons AGA and
AGG for the expression in E. coli of triosephosphate isomerase from
seven different species. Biotechnol Rep 13:42–48. https://doi.org/10
.1016/j.btre.2017.01.002.
32. Uppal T, Banerjee S, Sun Z, Verma SC, Robertson ES. 2014. KSHV
LANA–the master regulator of KSHV latency. Viruses 6:4961–4998.
https://doi.org/10.3390/v6124961.
33. Purushothaman P, Dabral P, Gupta N, Sarkar R, Verma SC. 2016. Genome
replication and maintenance. Front Microbiol 7:54. https://doi.org/10
.3389/fmicb.2016.00054.
34. Ueda K. 2018. KSHV genome replication and maintenance in latency.
Adv Exp Med Biol 1045:299–320. https://doi.org/10.1007/978-981-10
-7230-7_14.
35. Ballestas ME, Chatis PA, Kaye KM. 1999. Persistence of extrachromosomal
KSHV DNA mediated by latency-associated nuclear antigen. Science
284:641–644. https://doi.org/10.1126/science.284.5414.641.
36. Cotter MA, II, Robertson ES. 1999. The latency-associated nuclear antigen
tethers the Kaposi’s sarcoma-associated herpesvirus genome to host
chromosomes in body cavity-based lymphoma cells. Virology 264:
254–264. https://doi.org/10.1006/viro.1999.9999.
37. Grant MJ, Loftus MS, Stoja AP, Kedes DH, Smith MM. 2018. Microscopy
reveals structural mechanisms driving the nanoarchitecture of a viral
chromatin tether. Proc Natl Acad Sci U S A 115:4992–4997. https://doi
.org/10.1073/pnas.1721638115.
38. Juillard F, Tan M, Li S, Kaye KM. 2016. Sarcoma herpesvirus genome
persistence. Front Microbiol 7:1149. https://doi.org/10.3389/fmicb.2016
.01149.
39. Weller SK, Coen DM. 2012. Herpes simplex viruses: mechanisms of DNA
replication. Cold Spring Harb Perspect Biol 4:a013011. https://doi.org/
10.1101/cshperspect.a013011.
40. Deng Z, Kim ET, Vladimirova O, Dheekollu J, Wang Z, Newhart A, Liu D,
Myers JL, Hensley SE, Moffat J, Janicki SM, Fraser NW, Knipe DM, Weitz-
man MD, Lieberman PM. 2014. HSV-1 remodels host telomeres to facil-
itate viral replication. Cell Rep 9:2263–2278. https://doi.org/10.1016/j
.celrep.2014.11.019.
41. De Leo A, Deng Z, Vladimirova O, Chen HS, Dheekollu J, Calderon A, Myers
KA, Hayden J, Keeney F, Kaufer BB, Yuan Y, Robertson E, Lieberman PM.
2019. LANA oligomeric architecture is essential for KSHV nuclear body
formation and viral genome maintenance during latency. PLoS Pathog
15:e1007489. https://doi.org/10.1371/journal.ppat.1007489.
42. Li W, Avey D, Fu B, Wu JJ, Ma S, Liu X, Zhu F. 2016. Kaposi’s sarcoma-
associated herpesvirus inhibitor of cGAS (KicGAS), encoded by ORF52, is
an abundant tegument protein and is required for production of infec-
tious progeny viruses. J Virol 90:5329–5342. https://doi.org/10.1128/JVI
.02675-15.
43. Goldman SL, MacKay M, Afshinnekoo E, Melnick AM, Wu S, Mason CE.
2019. The impact of heterogeneity on single-cell sequencing. Front
Genet 10:8. https://doi.org/10.3389/fgene.2019.00008.
44. Rodriguez-Meira A, Buck G, Clark SA, Povinelli BJ, Alcolea V, Louka E,
McGowan S, Hamblin A, Sousos N, Barkas N, Giustacchini A, Psaila B,
Jacobsen SEW, Thongjuea S, Mead AJ. 2019. Unravelling intratumoral
heterogeneity through high-sensitivity single-cell mutational analysis
and parallel RNA sequencing. Mol Cell 73:1292–1305. https://doi.org/10
.1016/j.molcel.2019.01.009.
45. Russell AB, Trapnell C, Bloom JD. 2018. Extreme heterogeneity of influ-
enza virus infection in single cells. Elife 7:e32303. https://doi.org/10
.7554/eLife.32303.
46. Drayman N, Patel P, Vistain L, Tay S. 2019. HSV-1 single-cell analysis reveals
the activation of anti-viral and developmental programs in distinct sub-
populations. Elife 8:e46339. https://doi.org/10.7554/eLife.46339.
47. Liu D, Wang Y, Yuan Y. 2018. Kaposi’s sarcoma-associated herpesvirus K8
is an RNA binding protein that regulates viral DNA replication in coor-
dination with a noncoding RNA. J Virol 92:e02177-17. https://doi.org/10
.1128/JVI.02177-17.
48. Myoung J, Ganem D. 2011. Infection of primary human tonsillar lym-
phoid cells by KSHV reveals frequent but abortive infection of T cells.
Virology 413:1–11. https://doi.org/10.1016/j.virol.2010.12.036.
49. Scholz BA, Harth-Hertle ML, Malterer G, Haas J, Ellwart J, Schulz TF,
Kempkes B. 2013. Lytic reactivation of KSHV in CBF1/CSL deficient
human B cell lines. PLoS Pathog 9:e1003336. https://doi.org/10.1371/
journal.ppat.1003336.
50. Izumiya Y, Izumiya C, Hsia D, Ellison TJ, Luciw PA, Kung HJ. 2009.
NF-kappaB serves as a cellular sensor of Kaposi’s sarcoma-associated
herpesvirus latency and negatively regulates K-Rta by antagonizing the
RBP-Jkappa coactivator. J Virol 83:4435–4446. https://doi.org/10.1128/
JVI.01999-08.
51. Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D. 2002. The lytic switch
protein of KSHV activates gene expression via functional interaction with
RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev
16:1977–1989. https://doi.org/10.1101/gad.996502.
52. Campbell M, Watanabe T, Nakano K, Davis RR, Lyu Y, Tepper CG,
Durbin-Johnson B, Fujimuro M, Izumiya Y. 2018. KSHV episomes reveal
dynamic chromatin loop formation with domain-specific gene regula-
tion. Nat Commun 9:49. https://doi.org/10.1038/s41467-017-02089-9.
53. Gunther T, Schreiner S, Dobner T, Tessmer U, Grundhoff A. 2014. Influ-
ence of ND10 components on epigenetic determinants of early KSHV
latency establishment. PLoS Pathog 10:e1004274. https://doi.org/10
.1371/journal.ppat.1004274.
54. Toth Z, Papp B, Brulois K, Choi YJ, Gao SJ, Jung JU. 2016. LANA-mediated
recruitment of host polycomb repressive complexes onto the KSHV
genome during de novo infection. PLoS Pathog 12:e1005878. https://
doi.org/10.1371/journal.ppat.1005878.
55. Lyu Y, Nakano K, Davis RR, Tepper CG, Campbell M, Izumiya Y. 2017. ZIC2
is essential for maintenance of latency and is a target of an immediate
early protein during Kaposi’s sarcoma-associated herpesvirus lytic reac-
tivation. J Virol 91:e00980-17. https://doi.org/10.1128/JVI.00980-17.
56. Gunther T, Frohlich J, Herrde C, Ohno S, Burkhardt L, Adler H, Grundhoff
A. 2019. A comparative epigenome analysis of gammaherpesviruses
suggests cis-acting sequence features as critical mediators of rapid
polycomb recruitment. PLoS Pathog 15:e1007838. https://doi.org/10
.1371/journal.ppat.1007838.
57. Brulois K, Toth Z, Wong LY, Feng P, Gao SJ, Ensser A, Jung JU. 2014.
Kaposi’s sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases
have stage-specific immune evasion roles during lytic replication. J Virol
88:9335–9349. https://doi.org/10.1128/JVI.00873-14.
58. Wang F, Guo Y, Li W, Lu C, Yan Q. 2018. Generation of a KSHV K13
deletion mutant for vFLIP function study. J Med Virol 90:753–760.
https://doi.org/10.1002/jmv.25009.
59. Wei X, Bai L, Dong L, Liu H, Xing P, Zhou Z, Wu S, Lan K. 2019. NCOA2
promotes lytic reactivation of Kaposi’s sarcoma-associated herpesvirus
by enhancing the expression of the master switch protein RTA. PLoS
Pathog 15:e1008160. https://doi.org/10.1371/journal.ppat.1008160.
60. Li W, Wang Q, Feng Q, Wang F, Yan Q, Gao SJ, Lu C. 2019. Oncogenic
KSHV-encoded interferon regulatory factor upregulates HMGB2 and
CMPK1 expression to promote cell invasion by disrupting a complex
lncRNA-OIP5-AS1/miR-218-5p network. PLoS Pathog 15:e1007578. https://
doi.org/10.1371/journal.ppat.1007578.
61. Lindstrom MS, Jurada D, Bursac S, Orsolic I, Bartek J, Volarevic S. 2018.
Nucleolus as an emerging hub in maintenance of genome stability and
cancer pathogenesis. Oncogene 37:2351–2366. https://doi.org/10.1038/
s41388-017-0121-z.
62. Guetg C, Santoro R. 2012. Formation of nuclear heterochromatin: the
nucleolar point of view. Epigenetics 7:811–814. https://doi.org/10.4161/
epi.21072.
63. Bender BJ, Coen DM, Strang BL. 2014. Dynamic and nucleolin-
dependent localization of human cytomegalovirus UL84 to the periph-
ery of viral replication compartments and nucleoli. J Virol 88:
11738–11747. https://doi.org/10.1128/JVI.01889-14.
64. Strang BL, Boulant S, Coen DM. 2010. Nucleolin associates with the
human cytomegalovirus DNA polymerase accessory subunit UL44 and is
necessary for efficient viral replication. J Virol 84:1771–1784. https://doi
.org/10.1128/JVI.01510-09.
65. Chen YL, Liu CD, Cheng CP, Zhao B, Hsu HJ, Shen CL, Chiu SJ, Kieff E, Peng
CW. 2014. Nucleolin is important for Epstein-Barr virus nuclear antigen
1-mediated episome binding, maintenance, and transcription. Proc Natl
Acad Sci U S A 111:243–248. https://doi.org/10.1073/pnas.1321800111.
Nakajima et al. Journal of Virology
April 2020 Volume 94 Issue 8 e01565-19 jvi.asm.org 16
66. Dillinger S, Straub T, Nemeth A. 2017. Nucleolus association of chromo-
somal domains is largely maintained in cellular senescence despite
massive nuclear reorganisation. PLoS One 12:e0178821. https://doi.org/
10.1371/journal.pone.0178821.
67. Everett RD, Boutell C, Orr A. 2004. Phenotype of a herpes simplex virus type
1 mutant that fails to express immediate-early regulatory protein ICP0. J
Virol 78:1763–1774. https://doi.org/10.1128/jvi.78.4.1763-1774.2004.
68. Izumiya Y, Izumiya C, Van Geelen A, Wang DH, Lam KS, Luciw PA, Kung
HJ. 2007. Kaposi’s sarcoma-associated herpesvirus-encoded protein ki-
nase and its interaction with K-bZIP. J Virol 81:1072–1082. https://doi
.org/10.1128/JVI.01473-06.
69. Tischer BK, Smith GA, Osterrieder N. 2010. En passant mutagenesis: a
two step markerless red recombination system. Methods Mol Biol 634:
421–430. https://doi.org/10.1007/978-1-60761-652-8_30.
70. Chen CP, Chuang F, Izumiya Y. 2018. Functional imaging of viral tran-
scription factories using 3D fluorescence microscopy. J Vis Exp 131:
56832. https://doi.org/10.3791/56832.
71. Fakhari FD, Dittmer DP. 2002. Charting latency transcripts in Kaposi’s
sarcoma-associated herpesvirus by whole-genome real-time quantita-
tive PCR. J Virol 76:6213–6223. https://doi.org/10.1128/jvi.76.12.6213
-6223.2002.
Reporter KSHV for Single-Cell Studies Journal of Virology
April 2020 Volume 94 Issue 8 e01565-19 jvi.asm.org 17
